nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP2C8—Mometasone—systemic scleroderma	0.239	0.476	CbGbCtD
Salmeterol—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0989	0.197	CbGbCtD
Salmeterol—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0951	0.189	CbGbCtD
Salmeterol—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0386	0.0768	CbGbCtD
Salmeterol—CYP3A4—Prednisone—systemic scleroderma	0.0308	0.0614	CbGbCtD
Salmeterol—Nausea—Pentoxifylline—systemic scleroderma	0.000426	0.000856	CcSEcCtD
Salmeterol—Malaise—Lisinopril—systemic scleroderma	0.000425	0.000854	CcSEcCtD
Salmeterol—Infection—Mycophenolic acid—systemic scleroderma	0.000425	0.000853	CcSEcCtD
Salmeterol—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000852	CcSEcCtD
Salmeterol—Diarrhoea—Mometasone—systemic scleroderma	0.000423	0.000851	CcSEcCtD
Salmeterol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000419	0.000842	CcSEcCtD
Salmeterol—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000417	0.000838	CcSEcCtD
Salmeterol—Palpitations—Lisinopril—systemic scleroderma	0.000417	0.000837	CcSEcCtD
Salmeterol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000416	0.000835	CcSEcCtD
Salmeterol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000415	0.000834	CcSEcCtD
Salmeterol—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000413	0.00083	CcSEcCtD
Salmeterol—Cough—Lisinopril—systemic scleroderma	0.000412	0.000827	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000408	0.00082	CcSEcCtD
Salmeterol—Tension—Mycophenolate mofetil—systemic scleroderma	0.000406	0.000815	CcSEcCtD
Salmeterol—Insomnia—Leflunomide—systemic scleroderma	0.000405	0.000814	CcSEcCtD
Salmeterol—Paraesthesia—Leflunomide—systemic scleroderma	0.000402	0.000808	CcSEcCtD
Salmeterol—Arthralgia—Lisinopril—systemic scleroderma	0.000402	0.000807	CcSEcCtD
Salmeterol—Chest pain—Lisinopril—systemic scleroderma	0.000402	0.000807	CcSEcCtD
Salmeterol—Myalgia—Lisinopril—systemic scleroderma	0.000402	0.000807	CcSEcCtD
Salmeterol—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000806	CcSEcCtD
Salmeterol—Anxiety—Lisinopril—systemic scleroderma	0.0004	0.000804	CcSEcCtD
Salmeterol—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000803	CcSEcCtD
Salmeterol—Dyspnoea—Leflunomide—systemic scleroderma	0.000399	0.000802	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000399	0.000801	CcSEcCtD
Salmeterol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000798	CcSEcCtD
Salmeterol—Discomfort—Lisinopril—systemic scleroderma	0.000397	0.000797	CcSEcCtD
Salmeterol—Dyspepsia—Leflunomide—systemic scleroderma	0.000394	0.000792	CcSEcCtD
Salmeterol—Vomiting—Mometasone—systemic scleroderma	0.000394	0.00079	CcSEcCtD
Salmeterol—Dry mouth—Lisinopril—systemic scleroderma	0.000393	0.000789	CcSEcCtD
Salmeterol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000391	0.000785	CcSEcCtD
Salmeterol—Rash—Mometasone—systemic scleroderma	0.00039	0.000784	CcSEcCtD
Salmeterol—Asthenia—Captopril—systemic scleroderma	0.00039	0.000783	CcSEcCtD
Salmeterol—Dermatitis—Mometasone—systemic scleroderma	0.00039	0.000783	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000389	0.000782	CcSEcCtD
Salmeterol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000388	0.000779	CcSEcCtD
Salmeterol—Headache—Mometasone—systemic scleroderma	0.000388	0.000779	CcSEcCtD
Salmeterol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000387	0.000778	CcSEcCtD
Salmeterol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000387	0.000776	CcSEcCtD
Salmeterol—Fatigue—Leflunomide—systemic scleroderma	0.000386	0.000776	CcSEcCtD
Salmeterol—Oedema—Lisinopril—systemic scleroderma	0.000385	0.000773	CcSEcCtD
Salmeterol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000385	0.000773	CcSEcCtD
Salmeterol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000384	0.000771	CcSEcCtD
Salmeterol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00077	CcSEcCtD
Salmeterol—Pain—Leflunomide—systemic scleroderma	0.000383	0.00077	CcSEcCtD
Salmeterol—Constipation—Leflunomide—systemic scleroderma	0.000383	0.00077	CcSEcCtD
Salmeterol—Infection—Lisinopril—systemic scleroderma	0.000382	0.000768	CcSEcCtD
Salmeterol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000381	0.000765	CcSEcCtD
Salmeterol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000763	CcSEcCtD
Salmeterol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000759	CcSEcCtD
Salmeterol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000376	0.000756	CcSEcCtD
Salmeterol—Tachycardia—Lisinopril—systemic scleroderma	0.000376	0.000755	CcSEcCtD
Salmeterol—Abdominal pain—Azathioprine—systemic scleroderma	0.000375	0.000753	CcSEcCtD
Salmeterol—Body temperature increased—Azathioprine—systemic scleroderma	0.000375	0.000753	CcSEcCtD
Salmeterol—Skin disorder—Lisinopril—systemic scleroderma	0.000374	0.000751	CcSEcCtD
Salmeterol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000749	CcSEcCtD
Salmeterol—Diarrhoea—Captopril—systemic scleroderma	0.000372	0.000747	CcSEcCtD
Salmeterol—Irritability—Methotrexate—systemic scleroderma	0.000371	0.000745	CcSEcCtD
Salmeterol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000369	0.000742	CcSEcCtD
Salmeterol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000369	0.00074	CcSEcCtD
Salmeterol—Nausea—Mometasone—systemic scleroderma	0.000368	0.000738	CcSEcCtD
Salmeterol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000366	0.000736	CcSEcCtD
Salmeterol—Constipation—Mycophenolic acid—systemic scleroderma	0.000366	0.000734	CcSEcCtD
Salmeterol—Pain—Mycophenolic acid—systemic scleroderma	0.000366	0.000734	CcSEcCtD
Salmeterol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000734	CcSEcCtD
Salmeterol—Hyperglycaemia—Prednisone—systemic scleroderma	0.000363	0.000728	CcSEcCtD
Salmeterol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000724	CcSEcCtD
Salmeterol—Dizziness—Captopril—systemic scleroderma	0.000359	0.000722	CcSEcCtD
Salmeterol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000357	0.000717	CcSEcCtD
Salmeterol—Urticaria—Leflunomide—systemic scleroderma	0.000356	0.000715	CcSEcCtD
Salmeterol—Abdominal pain—Leflunomide—systemic scleroderma	0.000354	0.000711	CcSEcCtD
Salmeterol—Body temperature increased—Leflunomide—systemic scleroderma	0.000354	0.000711	CcSEcCtD
Salmeterol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000352	0.000707	CcSEcCtD
Salmeterol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000707	CcSEcCtD
Salmeterol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000707	CcSEcCtD
Salmeterol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000707	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000351	0.000704	CcSEcCtD
Salmeterol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000704	CcSEcCtD
Salmeterol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00035	0.000702	CcSEcCtD
Salmeterol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00035	0.000702	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000702	CcSEcCtD
Salmeterol—Insomnia—Lisinopril—systemic scleroderma	0.000348	0.000699	CcSEcCtD
Salmeterol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000698	CcSEcCtD
Salmeterol—Paraesthesia—Lisinopril—systemic scleroderma	0.000346	0.000694	CcSEcCtD
Salmeterol—Vomiting—Captopril—systemic scleroderma	0.000346	0.000694	CcSEcCtD
Salmeterol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000691	CcSEcCtD
Salmeterol—Dyspnoea—Lisinopril—systemic scleroderma	0.000343	0.000689	CcSEcCtD
Salmeterol—Rash—Captopril—systemic scleroderma	0.000343	0.000688	CcSEcCtD
Salmeterol—Dermatitis—Captopril—systemic scleroderma	0.000342	0.000688	CcSEcCtD
Salmeterol—Headache—Captopril—systemic scleroderma	0.000341	0.000684	CcSEcCtD
Salmeterol—Dyspepsia—Lisinopril—systemic scleroderma	0.000339	0.000681	CcSEcCtD
Salmeterol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000338	0.000679	CcSEcCtD
Salmeterol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000338	0.000679	CcSEcCtD
Salmeterol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000677	CcSEcCtD
Salmeterol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000677	CcSEcCtD
Salmeterol—Asthma—Methotrexate—systemic scleroderma	0.000336	0.000675	CcSEcCtD
Salmeterol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000673	CcSEcCtD
Salmeterol—Fatigue—Lisinopril—systemic scleroderma	0.000332	0.000667	CcSEcCtD
Salmeterol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000664	CcSEcCtD
Salmeterol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00033	0.000663	CcSEcCtD
Salmeterol—Pain—Lisinopril—systemic scleroderma	0.000329	0.000661	CcSEcCtD
Salmeterol—Constipation—Lisinopril—systemic scleroderma	0.000329	0.000661	CcSEcCtD
Salmeterol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000661	CcSEcCtD
Salmeterol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000658	CcSEcCtD
Salmeterol—Diarrhoea—Azathioprine—systemic scleroderma	0.000325	0.000652	CcSEcCtD
Salmeterol—Nausea—Captopril—systemic scleroderma	0.000323	0.000649	CcSEcCtD
Salmeterol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000322	0.000647	CcSEcCtD
Salmeterol—Asthenia—Leflunomide—systemic scleroderma	0.000321	0.000646	CcSEcCtD
Salmeterol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000317	0.000637	CcSEcCtD
Salmeterol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000316	0.000635	CcSEcCtD
Salmeterol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000315	0.000632	CcSEcCtD
Salmeterol—Dizziness—Azathioprine—systemic scleroderma	0.000314	0.00063	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000312	0.000627	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000617	CcSEcCtD
Salmeterol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000307	0.000616	CcSEcCtD
Salmeterol—Diarrhoea—Leflunomide—systemic scleroderma	0.000307	0.000616	CcSEcCtD
Salmeterol—Urticaria—Lisinopril—systemic scleroderma	0.000306	0.000614	CcSEcCtD
Salmeterol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000613	CcSEcCtD
Salmeterol—Body temperature increased—Lisinopril—systemic scleroderma	0.000304	0.000611	CcSEcCtD
Salmeterol—Abdominal pain—Lisinopril—systemic scleroderma	0.000304	0.000611	CcSEcCtD
Salmeterol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000608	CcSEcCtD
Salmeterol—Vomiting—Azathioprine—systemic scleroderma	0.000302	0.000606	CcSEcCtD
Salmeterol—Pneumonia—Methotrexate—systemic scleroderma	0.000301	0.000605	CcSEcCtD
Salmeterol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000604	CcSEcCtD
Salmeterol—Infestation NOS—Methotrexate—systemic scleroderma	0.0003	0.000602	CcSEcCtD
Salmeterol—Infestation—Methotrexate—systemic scleroderma	0.0003	0.000602	CcSEcCtD
Salmeterol—Rash—Azathioprine—systemic scleroderma	0.000299	0.000601	CcSEcCtD
Salmeterol—Dermatitis—Azathioprine—systemic scleroderma	0.000299	0.0006	CcSEcCtD
Salmeterol—Headache—Azathioprine—systemic scleroderma	0.000297	0.000597	CcSEcCtD
Salmeterol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000596	CcSEcCtD
Salmeterol—Dizziness—Leflunomide—systemic scleroderma	0.000296	0.000595	CcSEcCtD
Salmeterol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000292	0.000587	CcSEcCtD
Salmeterol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000291	0.000585	CcSEcCtD
Salmeterol—Immune system disorder—Prednisone—systemic scleroderma	0.000291	0.000584	CcSEcCtD
Salmeterol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000579	CcSEcCtD
Salmeterol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000579	CcSEcCtD
Salmeterol—Arrhythmia—Prednisone—systemic scleroderma	0.000288	0.000577	CcSEcCtD
Salmeterol—Vomiting—Leflunomide—systemic scleroderma	0.000285	0.000572	CcSEcCtD
Salmeterol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000284	0.00057	CcSEcCtD
Salmeterol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000283	0.000568	CcSEcCtD
Salmeterol—Epistaxis—Methotrexate—systemic scleroderma	0.000283	0.000568	CcSEcCtD
Salmeterol—Rash—Leflunomide—systemic scleroderma	0.000283	0.000567	CcSEcCtD
Salmeterol—Dermatitis—Leflunomide—systemic scleroderma	0.000282	0.000567	CcSEcCtD
Salmeterol—Mental disorder—Prednisone—systemic scleroderma	0.000282	0.000566	CcSEcCtD
Salmeterol—Nausea—Azathioprine—systemic scleroderma	0.000282	0.000566	CcSEcCtD
Salmeterol—Headache—Leflunomide—systemic scleroderma	0.000281	0.000564	CcSEcCtD
Salmeterol—Malnutrition—Prednisone—systemic scleroderma	0.00028	0.000563	CcSEcCtD
Salmeterol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000558	CcSEcCtD
Salmeterol—Asthenia—Lisinopril—systemic scleroderma	0.000276	0.000555	CcSEcCtD
Salmeterol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000554	CcSEcCtD
Salmeterol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000272	0.000546	CcSEcCtD
Salmeterol—Rash—Mycophenolic acid—systemic scleroderma	0.00027	0.000541	CcSEcCtD
Salmeterol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000269	0.000541	CcSEcCtD
Salmeterol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000538	CcSEcCtD
Salmeterol—Headache—Mycophenolic acid—systemic scleroderma	0.000268	0.000538	CcSEcCtD
Salmeterol—Pharyngitis—Methotrexate—systemic scleroderma	0.000267	0.000536	CcSEcCtD
Salmeterol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000536	CcSEcCtD
Salmeterol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000536	CcSEcCtD
Salmeterol—Nausea—Leflunomide—systemic scleroderma	0.000266	0.000535	CcSEcCtD
Salmeterol—Diarrhoea—Lisinopril—systemic scleroderma	0.000263	0.000529	CcSEcCtD
Salmeterol—Ill-defined disorder—Prednisone—systemic scleroderma	0.00026	0.000522	CcSEcCtD
Salmeterol—Agitation—Prednisone—systemic scleroderma	0.000257	0.000517	CcSEcCtD
Salmeterol—Angioedema—Prednisone—systemic scleroderma	0.000256	0.000514	CcSEcCtD
Salmeterol—Dizziness—Lisinopril—systemic scleroderma	0.000255	0.000511	CcSEcCtD
Salmeterol—Nausea—Mycophenolic acid—systemic scleroderma	0.000254	0.00051	CcSEcCtD
Salmeterol—Malaise—Prednisone—systemic scleroderma	0.000253	0.000507	CcSEcCtD
Salmeterol—Cardiac disorder—Methotrexate—systemic scleroderma	0.00025	0.000501	CcSEcCtD
Salmeterol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000499	CcSEcCtD
Salmeterol—Vomiting—Lisinopril—systemic scleroderma	0.000245	0.000492	CcSEcCtD
Salmeterol—Immune system disorder—Methotrexate—systemic scleroderma	0.000243	0.000488	CcSEcCtD
Salmeterol—Rash—Lisinopril—systemic scleroderma	0.000243	0.000488	CcSEcCtD
Salmeterol—Dermatitis—Lisinopril—systemic scleroderma	0.000243	0.000487	CcSEcCtD
Salmeterol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000242	0.000487	CcSEcCtD
Salmeterol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000486	CcSEcCtD
Salmeterol—Hypertension—Prednisone—systemic scleroderma	0.000242	0.000486	CcSEcCtD
Salmeterol—Headache—Lisinopril—systemic scleroderma	0.000241	0.000484	CcSEcCtD
Salmeterol—Myalgia—Prednisone—systemic scleroderma	0.000239	0.000479	CcSEcCtD
Salmeterol—Arthralgia—Prednisone—systemic scleroderma	0.000239	0.000479	CcSEcCtD
Salmeterol—Anxiety—Prednisone—systemic scleroderma	0.000238	0.000477	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000237	0.000476	CcSEcCtD
Salmeterol—Discomfort—Prednisone—systemic scleroderma	0.000236	0.000473	CcSEcCtD
Salmeterol—Mental disorder—Methotrexate—systemic scleroderma	0.000236	0.000473	CcSEcCtD
Salmeterol—Malnutrition—Methotrexate—systemic scleroderma	0.000234	0.00047	CcSEcCtD
Salmeterol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000464	CcSEcCtD
Salmeterol—Nausea—Lisinopril—systemic scleroderma	0.000229	0.000459	CcSEcCtD
Salmeterol—Oedema—Prednisone—systemic scleroderma	0.000229	0.000459	CcSEcCtD
Salmeterol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000229	0.000459	CcSEcCtD
Salmeterol—Infection—Prednisone—systemic scleroderma	0.000227	0.000456	CcSEcCtD
Salmeterol—Back pain—Methotrexate—systemic scleroderma	0.000226	0.000455	CcSEcCtD
Salmeterol—Nervous system disorder—Prednisone—systemic scleroderma	0.000224	0.00045	CcSEcCtD
Salmeterol—Tachycardia—Prednisone—systemic scleroderma	0.000223	0.000448	CcSEcCtD
Salmeterol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000448	CcSEcCtD
Salmeterol—Skin disorder—Prednisone—systemic scleroderma	0.000222	0.000446	CcSEcCtD
Salmeterol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000217	0.000436	CcSEcCtD
Salmeterol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000431	CcSEcCtD
Salmeterol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000427	CcSEcCtD
Salmeterol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000427	CcSEcCtD
Salmeterol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000424	CcSEcCtD
Salmeterol—Malaise—Methotrexate—systemic scleroderma	0.000211	0.000424	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000208	0.000418	CcSEcCtD
Salmeterol—Insomnia—Prednisone—systemic scleroderma	0.000207	0.000415	CcSEcCtD
Salmeterol—Paraesthesia—Prednisone—systemic scleroderma	0.000205	0.000412	CcSEcCtD
Salmeterol—Cough—Methotrexate—systemic scleroderma	0.000204	0.00041	CcSEcCtD
Salmeterol—Dyspepsia—Prednisone—systemic scleroderma	0.000201	0.000404	CcSEcCtD
Salmeterol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000402	CcSEcCtD
Salmeterol—Arthralgia—Methotrexate—systemic scleroderma	0.000199	0.0004	CcSEcCtD
Salmeterol—Myalgia—Methotrexate—systemic scleroderma	0.000199	0.0004	CcSEcCtD
Salmeterol—Chest pain—Methotrexate—systemic scleroderma	0.000199	0.0004	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000198	0.000398	CcSEcCtD
Salmeterol—Fatigue—Prednisone—systemic scleroderma	0.000197	0.000396	CcSEcCtD
Salmeterol—Discomfort—Methotrexate—systemic scleroderma	0.000197	0.000396	CcSEcCtD
Salmeterol—Constipation—Prednisone—systemic scleroderma	0.000196	0.000393	CcSEcCtD
Salmeterol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000191	0.000384	CcSEcCtD
Salmeterol—Infection—Methotrexate—systemic scleroderma	0.00019	0.000381	CcSEcCtD
Salmeterol—Feeling abnormal—Prednisone—systemic scleroderma	0.000188	0.000378	CcSEcCtD
Salmeterol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000187	0.000376	CcSEcCtD
Salmeterol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000187	0.000376	CcSEcCtD
Salmeterol—Skin disorder—Methotrexate—systemic scleroderma	0.000186	0.000373	CcSEcCtD
Salmeterol—Urticaria—Prednisone—systemic scleroderma	0.000182	0.000365	CcSEcCtD
Salmeterol—Abdominal pain—Prednisone—systemic scleroderma	0.000181	0.000363	CcSEcCtD
Salmeterol—Body temperature increased—Prednisone—systemic scleroderma	0.000181	0.000363	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000174	0.00035	CcSEcCtD
Salmeterol—Insomnia—Methotrexate—systemic scleroderma	0.000173	0.000347	CcSEcCtD
Salmeterol—Paraesthesia—Methotrexate—systemic scleroderma	0.000172	0.000345	CcSEcCtD
Salmeterol—Dyspnoea—Methotrexate—systemic scleroderma	0.00017	0.000342	CcSEcCtD
Salmeterol—Hypersensitivity—Prednisone—systemic scleroderma	0.000168	0.000338	CcSEcCtD
Salmeterol—Dyspepsia—Methotrexate—systemic scleroderma	0.000168	0.000338	CcSEcCtD
Salmeterol—Fatigue—Methotrexate—systemic scleroderma	0.000165	0.000331	CcSEcCtD
Salmeterol—Asthenia—Prednisone—systemic scleroderma	0.000164	0.000329	CcSEcCtD
Salmeterol—Pain—Methotrexate—systemic scleroderma	0.000163	0.000328	CcSEcCtD
Salmeterol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000157	0.000316	CcSEcCtD
Salmeterol—Diarrhoea—Prednisone—systemic scleroderma	0.000156	0.000314	CcSEcCtD
Salmeterol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000156	0.000314	CcSEcCtD
Salmeterol—Urticaria—Methotrexate—systemic scleroderma	0.000152	0.000305	CcSEcCtD
Salmeterol—Dizziness—Prednisone—systemic scleroderma	0.000151	0.000304	CcSEcCtD
Salmeterol—Abdominal pain—Methotrexate—systemic scleroderma	0.000151	0.000303	CcSEcCtD
Salmeterol—Body temperature increased—Methotrexate—systemic scleroderma	0.000151	0.000303	CcSEcCtD
Salmeterol—Vomiting—Prednisone—systemic scleroderma	0.000145	0.000292	CcSEcCtD
Salmeterol—Rash—Prednisone—systemic scleroderma	0.000144	0.00029	CcSEcCtD
Salmeterol—Dermatitis—Prednisone—systemic scleroderma	0.000144	0.000289	CcSEcCtD
Salmeterol—Headache—Prednisone—systemic scleroderma	0.000143	0.000288	CcSEcCtD
Salmeterol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000141	0.000283	CcSEcCtD
Salmeterol—Asthenia—Methotrexate—systemic scleroderma	0.000137	0.000275	CcSEcCtD
Salmeterol—Nausea—Prednisone—systemic scleroderma	0.000136	0.000273	CcSEcCtD
Salmeterol—Diarrhoea—Methotrexate—systemic scleroderma	0.000131	0.000263	CcSEcCtD
Salmeterol—Dizziness—Methotrexate—systemic scleroderma	0.000126	0.000254	CcSEcCtD
Salmeterol—Vomiting—Methotrexate—systemic scleroderma	0.000121	0.000244	CcSEcCtD
Salmeterol—Rash—Methotrexate—systemic scleroderma	0.00012	0.000242	CcSEcCtD
Salmeterol—Dermatitis—Methotrexate—systemic scleroderma	0.00012	0.000242	CcSEcCtD
Salmeterol—Headache—Methotrexate—systemic scleroderma	0.00012	0.00024	CcSEcCtD
Salmeterol—Nausea—Methotrexate—systemic scleroderma	0.000114	0.000228	CcSEcCtD
